Journal
NATURE CELL BIOLOGY
Volume 6, Issue 9, Pages 810-816Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ncb0904-810
Keywords
-
Categories
Funding
- NIA NIH HHS [AG 020961, AG 009521] Funding Source: Medline
- NICHD NIH HHS [HD 07249, HD 018179] Funding Source: Medline
Ask authors/readers for more resources
The goal of regenerative medicine is to restore form and function to damaged tissues. One potential therapeutic approach involves the use of autologous cells derived from the bone marrow (bone marrow-derived cells, BMDCs). Advances in nuclear transplantation, experimental heterokaryon formation and the observed plasticity of gene expression and phenotype reported in multiple phyla provide evidence for nuclear plasticity. Recent observations have extended these findings to show that endogenous cells within the bone marrow have the capacity to incorporate into defective tissues and be reprogrammed. Irrespective of the mechanism, the potential for new gene expression patterns by BMDCs in recipient tissues holds promise for developing cellular therapies for both proliferative and post-mitotic tissues.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available